Cargando…
Siglec10—An immunosuppressor and negative predictor of survival prognosis in gliomas
Glioma is a type of tumor occurring in the central nervous system. In recent decades, specific gene mutations and molecular aberrations have been used to conduct the glioma classification and clinical decisions. Siglec10 is a member of the sialic acid-binding immunoglobulin superfamily. In this stud...
Autores principales: | Wang, Hesong, Feng, Yanyan, Zhang, Yuxiang, Wang, Ting, Xu, Heng, Zhi, Yuxing, Feng, Yuyin, Tian, Lichun, Yuan, Kai |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9709431/ https://www.ncbi.nlm.nih.gov/pubmed/36468012 http://dx.doi.org/10.3389/fgene.2022.873655 |
Ejemplares similares
-
High Expression Levels of SIGLEC9 Indicate Poor Outcomes of Glioma and Correlate With Immune Cell Infiltration
por: Xu, Heng, et al.
Publicado: (2022) -
Thymodepressin—Unforeseen Immunosuppressor
por: Deigin, Vladislav I., et al.
Publicado: (2021) -
Optimal immunosuppressor induces stable gut microbiota after liver transplantation
por: Jiang, Jian-Wen, et al.
Publicado: (2018) -
The Viral Interferon Regulatory Factors of KSHV: Immunosuppressors or Oncogenes?
por: Jacobs, Sarah R., et al.
Publicado: (2011) -
Structural alterations in the seminiferous tubules of rats treated with immunosuppressor tacrolimus
por: Caneguim, Breno H, et al.
Publicado: (2009)